XENON PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 239.76K shares, a 67.69% decline year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 1.38M shares, a 429.75% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 513.96K shares, a 24.60% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 285.68K shares, a 59.07% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.80M shares, a 73.21% increase from fiscal 2024.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.04M shares, a 77.03% increase from fiscal 2023.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 587.54K shares, a 24.74% decline from fiscal 2022.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 780.73K shares, a 13.10% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 239.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 2.42M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.38M shares 10-Q · filed 2026-05-07 | 2.92M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 513.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 1.80M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 285.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 1.70M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 742.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.59M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 259.81K shares 10-Q · filed 2026-05-07 | 1.12M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 412.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 1.04M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 179.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 817.10K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 267.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 643.86K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 180.42K shares 10-Q · filed 2025-05-12 | 654.28K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 189.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 587.54K shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 6.35K shares 10-Q · filed 2023-11-08 | 460.35K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 278.07K shares 10-Q · filed 2023-08-09 | 823.33K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 113.68K shares 10-Q · filed 2024-05-09 | 675.29K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 62.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 780.73K shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 369.33K shares 10-Q · filed 2023-11-08 | 1.02M shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 130.03K shares 10-Q · filed 2023-08-09 | 694.69K shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 219.11K shares 10-Q · filed 2023-05-09 | 786.99K shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 303.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 690.28K shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 41.97K shares 10-Q · filed 2022-11-08 | 405.10K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 222.33K shares 10-Q · filed 2022-08-09 | 363.50K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 122.40K shares 10-Q · filed 2022-05-10 | 195.89K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 18.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 171.81K shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 375.00 shares 10-Q · filed 2021-11-10 | 244.76K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 54.72K shares 10-Q · filed 2021-08-11 | 393.34K shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | 98.33K shares 10-Q · filed 2021-05-11 | 342.08K shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | 91.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 266.16K shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 148.95K shares 10-Q · filed 2020-11-05 | 188.13K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | 3.46K shares 10-Q · filed 2020-08-06 | 158.31K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | 22.40K shares 10-Q/A · filed 2020-05-26 | 188.90K shares derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-12-31 | 13.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 251.16K shares 10-K · filed 2020-03-09 |
| 2018-09-30 | 119.13K shares 10-Q · filed 2019-11-05 | 237.85K shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | 34.05K shares 10-Q · filed 2019-08-06 | 118.72K shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | 84.67K shares 10-Q · filed 2019-05-07 | 87.75K shares derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 71.01K shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 119.76K shares derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | 3.08K shares 10-Q · filed 2018-08-07 | 161.77K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | 67.92K shares 10-Q · filed 2018-05-08 | 172.97K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | 48.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 121.29K shares 10-K · filed 2018-03-07 |
| 2016-09-30 | 42.01K shares 10-Q · filed 2017-11-07 | 132.94K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 14.28K shares 10-Q · filed 2017-08-03 | 200.97K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 16.25K shares 10-Q · filed 2017-05-09 | 241.84K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 60.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 270.25K shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 110.04K shares 10-Q · filed 2016-11-03 | 210.47K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-06-30 | 55.16K shares 10-Q · filed 2016-08-03 | 101.46K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-03-31 | 44.66K shares 10-Q · filed 2016-05-10 | 46.30K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | 617.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | 2.42K shares 10-K · filed 2017-03-08 |
| 2014-09-30 | 1.03K shares 10-Q · filed 2015-11-10 | 6.01K shares derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-13 | 8.07K shares derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | 772.00 shares 10-Q/A · filed 2015-08-13 | |
| 2013-12-31 | 4.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | 8.33K shares 10-K · filed 2016-03-08 |
| 2013-09-30 | 3.09K shares 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |